Dana Matzen, Ph.D.,Dr. Matzen has been Vice President, Business and Corporate Development at IntelGenx Corp. since September 2016 and was our VP of Business Development since March 2016. Most recently, from May 2010 to March 2016, Dr. Matzen was Director, Business Development at Paladin Labs, an Endo International company, based in Montreal, Canada. During her time at Paladin, Dr. Matzen was responsible for in-licensing business opportunities for Canada, Africa and Latin America. In addition, Dr. Matzen was in charge for overseeing strategic initiatives for Paladin’s international out-licensing business including alliance management of more than 15 existing partners worldwide. More recently, Dr. Matzen joined the Marketing Team and led the successful launch of Iclusig in Canada.
Prior to joining Paladin, from September 2008 to May 2010, Dr. Matzen was Life Science Specialist at L.E.K. Consulting in London, UK and Los Angeles, U.S. From October 2006 to August 2008, Dr. Matzen was a Postdoctoral Scholar at UCSF focusing on cellular and molecular pharmacology. Dr. Matzen has published several peer-reviewed articles that have been referenced in over 100 publications and was awarded with the Genentech Foundation Postdoctoral Fellowship for outstanding research.
Dr. Matzen holds a Ph. D in Microbiology and Genetics from the University of Vienna (Max F. Perutz Laboratories) and a Masters degree in Nutritional Economics from the University Kiel, Germany.
What is Dana Matzen's net worth?
The estimated net worth of Dana Matzen is at least $8,350.00 as of March 30th, 2022. Dr. Matzen owns 50,000 shares of IntelGenx Technologies stock worth more than $8,350 as of January 4th. This net worth evaluation does not reflect any other investments that Dr. Matzen may own. Learn More about Dana Matzen's net worth.
How do I contact Dana Matzen?
Has Dana Matzen been buying or selling shares of IntelGenx Technologies?
Dana Matzen has not been actively trading shares of IntelGenx Technologies during the last quarter. Most recently, on Tuesday, April 13th, Dana Matzen bought 25,000 shares of IntelGenx Technologies stock. The stock was acquired at an average cost of $0.49 per share, with a total value of $12,250.00. Learn More on Dana Matzen's trading history.
